EU TRANSPARENCY REGISTER · 697023893816-22 · Belgium

EUROPEAN PHARMACEUTICAL LAW ASSOCIATION

EPLA

Category

NGO / platform

Country

Belgium

Brussels

Entity form

AISBL

Stated objectives

The aim of the Association is to contribute in Europe: - to a better knowledge of pharmaceutical law and related areas as a specific sector of general law. - to the development of pharmaceutical law and related areas, including to its inter…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2024-09-30

Last updated

2025-09-25

Other NGO / platform in Belgium

Other registered organisations in Belgium

Frequently asked questions

What is this organisation?
EUROPEAN PHARMACEUTICAL LAW ASSOCIATION (EPLA) is an interest representative listed in the EU Joint Transparency Register under ID 697023893816-22. Entity form: AISBL.
What category is it registered under?
It is registered under the category "Non-governmental organisations, platforms and networks and similar".
Which country is it based in?
The organisation is based in Belgium, Brussels.
What are its stated goals?
As declared by the registrant: The aim of the Association is to contribute in Europe: - to a better knowledge of pharmaceutical law and related areas as a specific sector of general law. - to the development of pharmaceutical law and related areas, including to its inter…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 697023893816-22.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-05 · Commission Reuse Decision 2011/833/EU